Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non-cash Items (2020 - 2023)

Historic Non-cash Items for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $24.1 million.

  • Terns Pharmaceuticals' Non-cash Items rose 91255.53% to $24.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $24.1 million, marking a year-over-year increase of 91255.53%. This contributed to the annual value of $2.5 million for FY2022, which is 3097.22% up from last year.
  • Per Terns Pharmaceuticals' latest filing, its Non-cash Items stood at $24.1 million for Q3 2023, which was up 91255.53% from $3.1 million recorded in Q2 2023.
  • In the past 5 years, Terns Pharmaceuticals' Non-cash Items ranged from a high of $34.0 million in Q1 2021 and a low of $2.0 million during Q1 2022
  • For the 4-year period, Terns Pharmaceuticals' Non-cash Items averaged around $18.9 million, with its median value being $24.4 million (2021).
  • In the last 5 years, Terns Pharmaceuticals' Non-cash Items tumbled by 9410.02% in 2022 and then surged by 91255.53% in 2023.
  • Over the past 4 years, Terns Pharmaceuticals' Non-cash Items (Quarter) stood at $26.7 million in 2020, then grew by 7.12% to $28.6 million in 2021, then fell by 25.87% to $21.2 million in 2022, then rose by 13.68% to $24.1 million in 2023.
  • Its Non-cash Items was $24.1 million in Q3 2023, compared to $3.1 million in Q2 2023 and $2.8 million in Q1 2023.